Alik Farber, MD

James Utley Professor and Chair of Surgery, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Alik Farber is the Surgeon-in-Chief at BMC. He is also the James Utley Professor and Chair of Surgery at Boston University Chobanian & Avedisian School of Medicine.

Dr. Farber is an expert in vascular and endovascular intervention to treat peripheral arterial disease, open and endovascular abdominal and thoracic aortic aneurysm repair, the treatment of diabetic foot problems, carotid artery surgery and stenting, and dialysis access. He is a prolific researcher who has published more than 260 peer-reviewed articles and has served as a principal investigator (PI) for a number of clinical trials, including the recently completed BEST-CLI (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia) trial. Dr. Farber was a national PI for this international, randomized controlled trial.

Dr. Farber received his medical degree from Harvard Medical School and bachelor's degree from Brown University. He completed his residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at Southern Illinois School of Medicine. Dr. Farber is a member of numerous national and regional medical and surgical societies.

Publications

  • Published 9/10/2025

    McNamara T, Zhu M, Rodriguez D, Arinze N, Cheng TW, Farber A, King EG, Kalish J, Maaneb de Macedo K, Alonso A, Siracuse JJ. Association of Food and Housing Insecurity with Outcomes After Revascularization for Chronic Limb-Threatening Ischemia. J Vasc Surg. 2025 Sep 10. PMID: 40939901.

    Read at: PubMed

  • Published 9/3/2025

    Patel N, Farber A, King E, Malas M, Alonso A, Chitalia V, Lotfollahzadeh S, Columbo JA, Goodney PP, Siracuse JJ. Upper Extremity Arteriovenous Grafts are Less Likely to be Abandoned Compared to Autogenous Fistulas Despite a Higher Reintervention Rate. Ann Vasc Surg. 2025 Sep 03; 121:654-663. PMID: 40912639.

    Read at: PubMed

  • Published 8/29/2025

    Alameddine D, Hamouda M, Doros G, Conte MS, Rosenfield K, Strong MB, Menard MT, Farber A, Hamdan A, Malas M, Ochoa Chaar CI. Insulin therapy and outcomes of revascularization procedures for chronic-limb threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2025 Aug 29. PMID: 40886741.

    Read at: PubMed

  • Published 8/28/2025

    Jones DW, Farber A, Armstrong DG, Azene E, Duncan A, Todoran TM, Doros G, Strong MB, Rosenfield K, Conte MS, Menard MT. Characteristics of multidisciplinary limb preservation teams and their impact on outcomes in the BEST-CLI trial. J Vasc Surg. 2025 Aug 28. PMID: 40885461.

    Read at: PubMed

  • Published 8/25/2025

    Okazaki RA, Rizvi SH, Bretón-Romero R, Zhou Y, Weisbrod RM, Li Z, Farb MG, Farber A, Hamburg NM. Novel microRNA pathways of impaired angiogenesis in human peripheral artery disease adipose tissue. Vasc Med. 2025 Aug 25; 1358863X251359542. PMID: 40855713.

    Read at: PubMed

View All 400 Publications:   View Full Profile in BUMC

Other Positions

  • Surgeon-in-Chief
    Boston Medical Center
  • Professor, Surgery
    Boston University Chobanian & Avedisian School of Medicine
  • Associate Chief Medical Officer for Surgical Services
    Boston Medical Center
  • Professor, Radiology
    Boston University Chobanian & Avedisian School of Medicine
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Websites

Education

  • Harvard Medical School, MD
  • Brandeis University, MBA
  • Brown University, BS

View all profiles